| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |